Published On: April 16th, 2020Categories: Featured Applications

IBM files a patent relating to wearable technology employed in injury detection and skills training. Read about this and other recently published patent applications.

In this post, we introduce you to a few recent patent applications from IBM, Microsoft, Apple, Intel, Medtronic, Boston Scientific, Novartis, Merck, and Roche.

IBM Files a Patent Relating to Wearable Technology Employed in Injury Detection and Skills Training

US patent application 20200118459 discloses a method for automatically detecting a potential injury-causing movement of a person based on data obtained from wearable apparel having one or more sensors. The wearable apparel may also initiate the application of physical stimuli that causes the person to adjust the movement to prevent the injury. The figures below illustrate two examples of the apparel with sensors used to detect injury and to facilitate skills training.


Microsoft Seeks a Patent for Techniques for Application Launching in a Multi-Display Device

US patent application 20200117473 discloses a technique for determining an application launching behavior based on context information of a multi-display device and accordingly launching the application on the multi-display device. The figure below depicts an implementation scenario for application launching based on contextual information.

Apple Aims to Patent a Method for Automatically Setting Alarms and Notifications

US patent application 20200120198 discusses a personal electronic device being programmed to automatically respond to data sent by various sensors from which the user’s activity may be inferred. One or more alarms on the personal device may be temporarily disabled or enabled based on the inferred activity. A block diagram of the device is illustrated below.

Intel Pursues a Patent Relating to Bone Conduction Context Detection

US application 20200120417 discloses an apparatus for bone conduction detection. The apparatus includes sensors to generate vibration information having sound data and motion data from the bone structure of a user, a signal modifier to generate a modified signal based on the vibration information, and a communicator to transmit the modified signal for output via a speaker. The illustration depicts an example system.

Medtronic Seeks a Patent for a Knee Ligament Balancer and Another for an Extra-Cardiovascular Cardioverter Defibrillator

US patent application 20200113714 relates to an orthopedic surgical device for knee ligament balancing. The device includes a pad to be positioned within a patient’s knee joint, a sensor array in the pad that generates a signal indicative of the force within the knee joint, and a display that provides a visual indication of the force. The figure below shows the knee ligament balancer.

Another application 20200114158 describes an implantable cardioverter defibrillator for sensing cardiac electrical signals and detecting tachyarrhythmia episodes, using extra-cardiovascular electrodes, by comparing an unconfirmed beat count to a rejection threshold. The figure below shows a patient implanted with the extra-cardiovascular system.

Boston Scientific Files a Patent for a Minimally Invasive Implant Device

US patent application 20200113664 presents a minimally invasive apparatus for treating incontinence such as fecal incontinence, comprising a sling device having an extension arm and a tissue support portion having an eyelet, wherein a portion of the extension arm is adapted to slide through and attach with the eyelet. The image below depicts a pelvic implant device.

Merck Seeks to Patent Cyclic Dinucleotide Sting Agonists

US patent application 20200113924 discloses the structure of a novel cyclic dinucleotide compound that activates the Stimulator of Interferon Genes (STING) pathway for the treatment of cell-proliferation disorders such as cancer.

Roche Aims to Patent Tetralin and Indane Derivatives

US patent application 20200115333 presents the structures of novel Tetralin and Indane derivatives that are useful for treating CNS diseases.

Novartis Seeks to Patent an Injector Device

US patent application 20200114068 presents a driving mechanism for a novel injector device comprising a coil spring having a proximal end and a distal end, a spring guide adapted to guide the movement of the coil spring, and an actuator adapted to cause a force on the proximal end of the coil spring. The illustration depicts an injector device having the driving mechanism described in the invention.

Let us know what you’d like to see in our next blog/webinar. Take the Reader Poll

Have any content requests?

You can let us know at [email protected]

Get the latest IP data, insights and inspiration directly delivered to your inbox